INTAGE HOLDINGS Inc. Logo

INTAGE HOLDINGS Inc.

Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.

4326 | T

Overview

Corporate Details

ISIN(s):
JP3152790006
LEI:
Country:
Japan
Address:
千代田区神田練塀町3番地インテージ秋葉原ビル
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

INTAGE HOLDINGS Inc., established in 1960, is a leading marketing research and business intelligence group. The company operates through three core segments to provide data-driven insights and solutions. The Marketing Support (Consumer Goods & Services) division offers comprehensive support to clients, including consumer goods manufacturers, by leveraging panel research, custom research, and advanced data analysis. The Marketing Support (Healthcare) division assists pharmaceutical companies with research, development, and marketing activities through prescription data analysis and specialized market research. The Business Intelligence segment provides technology services encompassing software development, system operation, data center management, and AI-driven consulting to support enterprise management strategies and improve business processes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 08:30
Regulatory News Service
確認書
Japanese 8.9 KB
2025-09-24 08:30
Annual Report
有価証券報告書-第53期(2024/07/01-2025/06/30)
Japanese 1.6 MB
2025-02-06 07:30
Interim Report
半期報告書-第53期(2024/07/01-2025/06/30)
Japanese 268.3 KB
2025-02-06 07:30
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-10-01 08:05
Post-Annual General Meeting Information
臨時報告書
Japanese 28.5 KB
2024-09-26 09:48
Registration Form
確認書
Japanese 8.9 KB
2024-09-26 09:48
Governance Information
内部統制報告書-第52期(2023/07/01-2024/06/30)
Japanese 23.9 KB
2024-09-26 09:47
Registration Form
有価証券報告書-第52期(2023/07/01-2024/06/30)
Japanese 1.7 MB
2024-08-07 08:32
Board/Management Information
臨時報告書
Japanese 19.2 KB
2024-08-07 08:31
Audit Report / Information
臨時報告書
Japanese 20.6 KB
2024-06-17 08:33
Regulatory News Service
臨時報告書
Japanese 19.5 KB
2024-05-09 08:33
Quarterly Report
確認書
Japanese 9.0 KB
2024-05-09 08:33
Quarterly Report
四半期報告書-第52期第3四半期(2024/01/01-2024/03/31)
Japanese 218.2 KB
2024-04-22 08:31
M&A Activity
臨時報告書
Japanese 23.0 KB
2024-02-07 07:31
Report Publication Announcement
確認書
Japanese 9.1 KB

Automate Your Workflow. Get a real-time feed of all INTAGE HOLDINGS Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INTAGE HOLDINGS Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INTAGE HOLDINGS Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan
4893
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN
Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150

Talk to a Data Expert

Have a question? We'll get back to you promptly.